Publications by authors named "Mark Roh"

Claim this Profile
P
Post-Publication Discussion: Invitation for Reply.
Mark S Roh, Douglas S Tyler,

Ann Surg Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint Statement by the Surgery Journal Editors Group: Adopted by the Annals of Surgical Oncology.
Mark S Roh, Kelly M McMasters

Ann Surg Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reviewing the review: a qualitative assessment of the peer review process in surgical journals.
Catherine H Davis, Barbara L Bass, Kevin E Behrns, Keith D Lillemoe, O James Garden, Mark S Roh

Res Integr Peer Rev· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steps to Getting Your Manuscript Published in a High-Quality Medical Journal.
Charles M Balch, Kelly M McMasters, V Suzanne Klimberg, Timothy M Pawlik, Mitchell C Posner, Mark Roh

Ann Surg Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Annals of Surgical Oncology: An Oncology Journal for Surgeons.
Charles M Balch, Mark S Roh, Colleen M Hubona

Ann Surg Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celebrating the Annals of Surgical Oncology's 25-Year Anniversary: One of the Most Cited Surgical Journals in the World.
Charles M Balch, Mark Roh, Kelly M McMasters, Deborah Whippen

Ann Surg Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letters to the Editor Anthology: An e-Supplement Resource.
Mark Roh, Deborah Whippen, Charles Balch

Ann Surg Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking the Scientific and Educational Impact of the Annals of Surgical Oncology.
Charles M Balch, V Suzanne Klimberg, Kelly M McMasters, Timothy M Pawlik, Kenneth K Tanabe, Mark S Roh

Ann Surg Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
It's Tough to Make Predictions, Especially About the Future ... of Rectal Cancer.
Thomas J George, Mark S Roh

Oncology (Williston Park)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.
Carmen J Allegra, Greg Yothers, Michael J O'Connell, Robert W Beart, Timothy F Wozniak, Mark S Roh

J Natl Cancer Inst· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constituents of the leaves of Verbascum blattaria.
I-Soo Youn, Ah-Reum Han, Mark S Roh, Eun-Kyoung Seo

Nat Prod Commun· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annals of Surgical Oncology: the first 20 years.
Charles M Balch, Mark S Roh, Deborah Whippen, V Suzanne Klimberg

Ann Surg Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.
Michael J O'Connell, Linda H Colangelo, Robert W Beart, Nicholas J Petrelli, Carmen J Allegra, Mark S Roh

J Clin Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In memoriam: Donald L. Morton, MD (1934-2014): an icon in surgical oncology : past president, society of surgical oncology (1992-1993) and associate editor, annals of surgical oncology (1993-2014).
Charles M Balch, Mark S Roh, V Suzanne Klimberg, Deborah A Whippen

Ann Surg Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The coat protein of Alternanthera mosaic virus is the elicitor of a temperature-sensitive systemic necrosis in Nicotiana benthamiana, and interacts with a host boron transporter protein.
Hyoun-Sub Lim, Jiryun Nam, Eun-Young Seo, Moon Nam, Anna Maria Vaira, Mark Roh

Virology· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annals of Surgical Oncology: the global journal for surgeons treating patients with cancer.
Charles Balch, Deborah Whippen, V Suzanne Klimberg, Mark Roh

Ann Surg Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66.
Steven R Alberts, Mark S Roh, Michelle R Mahoney, Michael J O'Connell, David M Nagorney

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the Journal 2010: managing growth, extending our reach--now the official journal for the Society of Surgical Oncology and the American Society of Breast Surgeons.
Mark Roh, Deborah Whippen, Charles Balch

Ann Surg Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.
Mark S Roh, Linda H Colangelo, Michael J O'Connell, Greg Yothers, Melvin Deutsch

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection.
Dario Ribero, Steven A Curley, Hiroshi Imamura, David C Madoff, David M Nagorney, Mark Roh

Ann Surg Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving resectability of hepatic colorectal metastases: expert consensus statement by Abdalla et al.
Reid B Adams, Daniel G Haller, Mark S Roh

Ann Surg Oncol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.
Graeme J Poston, René Adam, Steven Alberts, Steven Curley, Juan Figueras, Mark Roh

J Clin Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staging of hepatocellular carcinoma.
Timothy M Pawlik, Eddie K Abdalla, Melanie Thomas, Mark S Roh, Gregory Y Lauwers

Hepatology· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staging classifications for hepatocellular carcinoma.
Mathew A Van Deusen, Eddie K Abdalla, Jean-Nicolas Vauthey, Mark S Roh

Expert Rev Mol Diagn· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases.
Georges Vlastos, David L Smith, S Eva Singletary, Nadeem Q Mirza, Todd M Tuttle, Mark S Roh

Ann Surg Oncol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis